Cutler Group LP Cti Biopharma Corp Call Options Transaction History

Cutler Group LP

4 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q4 2022 Feb 07, 2023	BUY	$4.45 - $6.17 $2,225 - $3,085	500 Added 12.5%	4,500 $2,000
Q3 2022 Oct 25, 2022	SELL	$5.36 - $7.43 $18,760 - $26,005	-3,500 Reduced 46.67%	4,000 $2,000
Q2 2022 Aug 04, 2022	SELL	$3.55 - $6.27 $62,480 - $110,351	-17,600 Reduced 70.12%	7,500 $13,000
Q1 2022 Apr 14, 2022	BUY	$1.9 - $5.23 $47,690 - $131,273	25,100 New	25,100 $44,000

Ticker CTIC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 114,385,000
Market Cap $1.04B
Description
CTI BioPharma Corp., a biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel targeted therapies for blood-related cancers in the United States. It offers VONJO (pacritinib), an investigational oral kinase inhibitor with specificity for JAK2, FLT3, IRAK1, and CSF1R for the treatment of adult patients w...

Get notified when there are updates to the investment portfolio of Cutler Group LP, based on Form 13F filings with the SEC.

Stay updated on Cutler Group LP with notifications on news.